ABOUT 23rd_BEF
> REGISTRATION​​​
​> SPONSORS
> SUPPORTERS​​
> NETWORKING
> VENUE​​​
> ACCOMMODATION​​​

> ABOUT LAST YEAR

SILVER SPONSORs

basel+

The Canton of Basel-Stadt contributes to the further development of convention-related tourism. Conventions are specifically acquired, developed and held, thus accessing a potential not yet exploited with benefits beyond tourism.

The objective of convention promotion is to increase the direct and indirect added value generated by conventions. Additionally, a further strengthening of Basel as the most innovative economic location and center of knowledge in Switzerland is targeted. By promoting conventions, we want to contribute to Basel remaining one of the most important trade fair and convention cities in Europe.

www.bs.ch/en/Portrait/cosmopolitan-basel.html

stifel

Stifel is a full-service investment bank, offering securities brokerage, trading, research, underwriting and corporate advisory services globally. Our expertise spans sectors and products in both public and private markets. We are driven by relationships, not transactions, and are committed to earning long-term trust from our clients. The breadth of our platform and experience of our people uniquely position us to provide a range of solutions with the ability to quickly pivot as client needs evolve.
 
We are pleased to welcome Torreya Partners to Stifel from 1 March 2023. Torreya adds a global investment banking boutique serving companies in the life sciences industry. Since its inception in 2007, Torreya have advised clients on more than $100 billion worth of deals for biotechnology, branded pharmaceutical, generic pharmaceutical, and life sciences companies.

www.stifelinstitutional.com/global-coverage/europe/investment-banking/

---

Bronze sponsor

Merck KGaA, Darmstadt, Germany

We are Merck KGaA, Darmstadt, Germany, a vibrant science and technology company.

Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create.

The passion of our curious minds makes a positive difference to millions of people’s lives every day.

In Healthcare, we discover unique ways to treat the most challenging diseases, such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Electronics, we develop science that sits inside technologies and changes the way we access, store, process, and display information.

Everything we do is fueled by a belief in science and technology as a force for good. A belief that has driven our work since 1668 and will continue to inspire us to find more joyful and sustainable ways to live.

We are curious minds dedicated to human progress.

​www.merckgroup.com/en/company/partnering/collaboration/collaboration-in-healthcare/strategic-focus-and-partnerships.html

---

CONTRIBUTING SPONSOR

NOVO HOLDINGS A/S

Novo Ventures is a global team of investment professionals employed by Novo affiliates that supports Novo Holdings’ investments in private, public and structured product opportunities in the life sciences industry. Novo Holdings A/S is a private limited liability company wholly owned by the Novo Nordisk Foundation. It is the holding and investment company of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is responsible for managing the Foundation’s assets. Novo Holdings is recognized as a world-leading life science investor with a focus on creating long-term value. As a life science investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings also manages a broad portfolio of diversified financial assets. 

https://www.novoholdings.dk/

PharmaVentures Ltd.

PharmaVentures is a premier transaction advisory firm and a leading international company in partnering, M&A deals and strategic alliances. For the past 30 years, PharmaVentures has acted as advisor on over 900 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide.

PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts from innovators to large pharma makes us uniquely placed to support business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest.

PharmaVentures’ services include:
•    M&A (divestments, mergers, acquisitions, and strategic transactions)
•    Licensing (in and out licensing)
•    Fundraising
•    Strategy (commercialisation, deal strategy, due diligence, market entry)
•    Valuation and Positioning (licensing, M&A, fundraising, and expert testimonies)

PharmaVentures is based in Oxford, UK, and employs over 20 professionals and has associates in Asia-Pacific.
PharmaVentures Capital Ltd is a wholly owned subsidiary of PharmaVentures Ltd. All regulated activities are delivered through PharmaVentures Capital Ltd, which is authorised and regulated by the Financial Conduct Authority (741356).

www.pharmaventures.com/